medigraphic.com
ISSN 1729-519X (Print)

2020, Number S1

<< Back Next >>

Revista Habanera de Ciencias Médicas 2020; 19 (S1)

Clinical aspects related to the Severe acute respiratory syndrome (SARS-CoV-2)

Hernández RJ

Language: Spanish
References: 43
Page: 1-18
PDF size: 1000.31 Kb.


ABSTRACT

Introduction: The 2019 novel coronavirus (2019-nCoV) can cause diseases in both animals and humans.
Objective: To describe some characteristics of the clinical behavior of COVID-19 in people affected by this disease.
Material and Methods: A search for relevant literature on the subject was carried out in the first quarter of 2020. Pubmed, Google and Google Scholar were used as search engines to locate scientific information. As eligibility criteria, review articles, research articles and web pages that, in general, were less than 5 years old, were evaluated. This allowed the study of 60 articles, of which 43 were referenced.
Development: COVID-19 is a zoonotic disease caused by a new β-coronavirus and its evolution in the form of a pandemic, affects more males and people with certain comorbidities. Most cases occur approximately from 3 to 7 days after exposure, although in some people it can take up to 14 days for symptoms to appear. The symptoms can include fever, runny nose, sore throat, cough, fatigue, muscle aches, shortness of breath, expectoration, hemoptysis, and diarrhea. The disease can be expressed with a clinical picture from very mild to extremely serious manifestations, which can even cause death.
Conclusions: COVID-19 has been responsible for significant morbidity and mortality worldwide, especially in adults. Its clinical behavior includes respiratory, general, and digestive symptoms and signs. The fatal outcome is more common in people who have other health problems.


REFERENCES

  1. Hidalgo MM. Las enfermedades infecciosas: el gran desafío de seguridad en el siglo XXl. Cuadernos de estrategia [Internet]. 2019 [Citado 29/03/2020];203:37-80. Disponible en: Disponible en: http://dialnet.unirioja.es/servlet/articulo?codigo=7269522

  2. Trilla A. Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19. Medicina Clínica [Internet].2020 [Citado 29/03/2020];154(5):175-7. Disponible en: Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094554/

  3. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [Citado 20/03/2020]. Disponible en: Disponible en: http://www.revistaacorl.org/index.php/acorl/article/download/475/383

  4. OMS. Preguntas y respuestas sobre la enfermedad por coronavirus (COVID 19). [Internet] Ginebra: OMS; 2020 [Citado 29/03/2020]. Disponible en: Disponible en: http://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses

  5. American Diabetes Association. COVID-19 (Coronavirus) [Internet]. Virginia U.S.: American Diabetes Association; 2017 [Citado 21/03/2020]. Disponible en: Disponible en: http://www.diabetes.org/diabetes/treatment-care/planning-sick-days/coronavirus

  6. Bonilla DK, Dhama K, Rodríguez AJ. Revisiting the One Health Approach in the Context of COVID-19: A Look into the Ecology of this Emerging Disease. Adv Anim Vet Sci. 2020; 8(3):234-7.

  7. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol [Internet]. 2020 [Citado 21/03/2020];92:[aprox. 4 p.] Disponible en: Disponible en: http://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25722

  8. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med [Internet]. 2020 [Citado 21/03/2020];382:727‐33. Disponible en: Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa2001017

  9. Xiaoxia L, Liqiong Zh, Hui D, Jingjing Zh, Yuan YL, Jingyu Q, et al SARS-CoV-2InfectioninChildren. Correspondence to the Editor. New England Journal of Medicine [Internet]. 2020 [Citado 21/03/2020];382:[aprox. 1 p.]. . Disponible en: Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMc2005073?cid=DM88773_&bid=171478755

  10. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol [Internet]. 2020 [Citado 21/03/2020];92:418‐23. Disponible en: Disponible en: http://doi.org/10.1002/jmv.25681

  11. De Wilde AH, Snijder EJ, KikkertM, van Hemert MJ. Host factors in coronavirus replication. Curr Top Microbiol Immunol [Internet]. 2018 [Citado 21/03/2020];419:1-42. Disponible en: Disponible en: http://link.springer.com/chapter/10.1007/82_2017_25

  12. Serra Valdés MA. Infección respiratoria aguda por COVID-19: una amenaza evidente. Rev haban cienc méd [Internet]. 2020 [Citado 25/03/2020];19(1):1-5. Disponible en: Disponible en: https://www.revhabanera.sld.cu/index.php/rhab/article/view/3171

  13. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance [Internet]. 2020 [Citado 21/03/2020];25(3):[aprox. 4 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988269/

  14. Fehr AR, Channappanavar R, Perlman S. Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus. Annual Review of Medicine [Internet]. 2020 [Citado 21/03/2020];68:387-99. Disponible en: Disponible en: http://www.annualreviews.org/doi/pdf/10.1146/annurev-med-051215-031152

  15. Hoffmann M, Kleine H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell [Internet] 2020 Apr [Citado 21/03/2020];181(3):[aprox. 6 p.]. Disponible en: Disponible en: http://www.sciencedirect.com/science/article/pii/S0092867420302294

  16. Del Río C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. Jama [Internet]. 2020 [Citado 07/03/2020];323(11):[aprox. 3 p.]. Disponible en: Disponible en: http://jamanetwork.com/journals/jama/article-abstract/2762510

  17. International Diabetes Federation. COVID-19 outbreak: guidance for people with diabetes. News [Internet] Brussels: International Diabetes Federation; 2020 [Citado 21/03/2020]. Disponible en: Disponible en: http://www.idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html

  18. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-74.

  19. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine [Internet]. 2020 Jan [Citado 21/03/2020];154(2):[aprox. 4 p.]. Disponible en: Disponible en: http://annals.org/AIM/FULLARTICLE/2762808/INCUBATION-PERIOD-CORONAVIRUS-DISEASE-2019-COVID-19-FROM-PUBLICLY-REPORTED

  20. Zhang B, Zhou X, Qiu Y, Feng F, Feng J, Jia Y, et al. Clinical characteristics of 82 death cases with COVID-19. medRxiv [Internet] 2020. [Citado 21/03/2020];1:[aprox. 2 p.]. Disponible en: Disponible en: http://www.medrxiv.org/content/10.1101/2020.02.26.20028191v1

  21. Bassey I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or Coronavirus Disease 2019 (COVID-19). Understanding the Pandemicdreamsformypeople. org is a platform for discussing Nigeria's challenges and ways to improve the nation for future generations. J Infect [Internet]. 2020 [Citado 21/03/2020];80(5):e14-e17. Disponible en: Disponible en: https://www.dreamsformypeople.org/?author=1

  22. Munster VJ, Koopmans M, Van Doremalen N, Van Riel D, De Wit E. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med [Internet]. 2020 [Citado 21/03/2020];382:692-4. Disponible en: Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMp2000929

  23. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT findings in patients with corona virus disease 2019 and its relationship with clinical features. Investigative Radiology [Internet]. 2020 [Citado 21/03/2020];96:[aprox. 6 p.]. Disponible en: Disponible en: http://radiology-kurume.jp/admin/pdf/kr_news/615e5cc44c16956.pdf

  24. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine [Internet]. 2020 [Citado 04/03/2020];382:[aprox. 4 p.]. Disponible en: Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMoa2002032

  25. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335-7.

  26. IntraMet. Tormenta de citoquinas e inmunosupresión [Internet]. Buenos Aires: IntraMet; 2019 [Citado 24/03/2020]. Disponible en: Disponible en: http://www.intramed.net/contenidover.asp?contenidoid=95720&fuente=inews&utm_source=inews&uid=428948

  27. IntraMet. COVID-19: Una propuesta de estadificación clínico-terapéutica [Internet]. Buenos Aires: IntraMet; 2019 [Citado 24/03/2020]. Disponible en: Disponible en: http://www.intramed.net/contenidover.asp?contenidoid=95766

  28. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

  29. US Centers for Disease Control and Prevention COVID-19. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19): United States, February 12-March 16, 2020. Morbidity and Mortality Weekly [Internet] United States: Centers for Disease Control and Prevention; 2020. [Citado 29/03/2020]. Disponible en: Disponible en: http://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6912e2-H.pdf?fbclid=IwAR31TK4W3TbfVkpwGanK-njxrs-KNk5WetAdK9KsJaVwoASxRNahBdJoxDM

  30. World health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. Ginebra: World health Organization; 2020 [Citado 29/03/2020]. Disponible en: Disponible en: http://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf

  31. Calliari LE, Almeida FJ, Noronha RM. Infections in children with diabetes. Jornal de Pediatria. 2020;96(1):39-46.

  32. OPS/OMS. Similitudes y diferencias entre la COVID-19 y la gripe [Internet]. Whasintong: OPS; 2020 [Citado 29/03/2020]. Disponible en: Disponible en: http://www.google.com/search?client=firefox-b-d&q=Mortalidad+por+la+COVID-19

  33. García M. Coronavirus: síntomas cardiacos que facilitan el contagio del Covid-19. Redacción Médica [Internet]. Madrid: Redacción Médica; 2020. [Citado 01/04/2020]. Disponible en: Disponible en: http://www.redaccionmedica.com/secciones/cardiologia/coronavirus-sintomas-cardiacos-que-facilitan-el-contagio-del-covid-19-3075

  34. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [Internet]. 2020 [Citado 31/03/2020];17(5):259-60. Disponible en: Disponible en: http://www.nature.com/articles/s41569-020-0360-5.pdf

  35. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet [Internet]. 2020 [Citado 31/03/2020];395(10223):497-506. Disponible en: Disponible en: http://reader.elsevier.com/reader/sd/pii/S0140673620301835?token=B3C6319B95AE4191EED0B6C2CB4C4F5BE38C185AB37EFD179CAD10BC9BAA727A3D73EFAB24E1F995489BA8109E375392

  36. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020 [Citado 01/04/2020];8(4):420-2. Disponible en:Disponible en:http://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930076-X

  37. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement 1 with coronavirus 2019 (COVID-19) infection. JAMA Network [Internet]. 2020 [Citado 01/04/2020];323(13):1257-65. Disponible en: Disponible en: http://jamanetwork.com/journals/jamacardiology/article-abstract/2763

  38. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J [Internet]. 2020 [Citado 01/04/2020];4:[aprox. 4 p.]. Disponible en: Disponible en: http://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa190/5807656

  39. Madjid M, Safavi P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Network [Internet]. 2020 [Citado 01/04/2020];323(13):1266-70. Disponible en: Disponible en: http://jamanetwork.com/journals/jamacardiology/fullarticle/2763846

  40. IntraMed. Vivir en confinamiento [Internet]. Madrid: IntraMed; 2020. [Citado 29/03/2020]. Disponible en: Disponible en: http://www.intramed.net/contenidover.asp?contenidoid=95785&fuente=inews&utm_source=inews&uid=428948

  41. Redacción médica. Prueba coronavirus: ¿qué diferencias hay entre un test rápido y un PCR? [Internet]. España: Redacción médica; 2020 [Citado 29/03/2020]. Disponible en: Disponible en: http://www.redaccionmedica.com/secciones/sanidad-hoy/prueba-coronavirus-diferencias-test-rapido-pcr-covid19-espana--8694

  42. TECIL SA. Noticias. Prueba rápida COVID-19 [Internet]. Barcelona: TECIL SA; 2020 [Citado 31/03/2020]. Disponible en: Disponible en: http://tecil.com/analizador/laboratorio/noticiesindex.php

  43. TECIL SA. Test rápido Coronavirus: Kit rápido inmunocromatográfico para detección de anticuerpos de Coronavirus nCoV-2019 en muestras sangre, suero o plasma [Internet]. Barcelona: TECIL SA ; 2020 [Citado 31/03/2020]. Disponible en: Disponible en: http://tecil.com/analizador/laboratorio/catalegdetall.php?idp=101&idcm=13&idc=34&idf=1&idioma=ES_ES




2020     |     www.medigraphic.com